Transapical minimally invasive aortic valve implantation: multicenter experience

Thomas Walther1, Paul Simon, Todd Dewey

  • 1University Leipzig, Heartcenter, Department of Cardiac Surgery, Leipzig, Germany. walt@medizin.uni-leipzig.de

Circulation
|September 14, 2007
PubMed
Summary

Minimally invasive transapical aortic valve implantation (TAP-AVI) offers safe, early success for high-risk aortic stenosis patients. Further studies are needed to assess long-term outcomes and expand its applications.